Connect a development opportunity with its next decision
We work on questions that pharmaceutical organisations can recognise in practice: how an evidence case is prepared, what affects medicines adoption, which material can meet an application’s requirements, and where a process may use resources more effectively.
Medicines evidence and implementation
PHARMORIS and the wider Medicines Intelligence programme examine evidence preparation, professional review, adoption conditions, and the assessment of realised value. A conversation can begin with a defined product, workflow, or market question.
Industrial research
ZYLON investigates bio-derived materials and recovery opportunities. PHARMORIS-ECO examines energy performance in fixed pharmaceutical chilling and freezing. Both programmes need an application, a credible comparison, and an understanding of the conditions an adopter must maintain.
Development partnerships
We welcome discussions that connect our research with relevant materials, specialist expertise, or a route to development. The first step is to establish the problem, the intended output, and how each organisation would contribute.